Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Synaptys Neuroscience Logo
Synaptys Neuroscience CB Rank
423907
Heat Score
86
Synaptys Neuroscience is a Biotechnology Research firm developing a new approach to treat people with dementia and alzheimer.
Founded
obfuscation
PrivateNon-equity Assistance Paris, Ile-de-France, France1-10 www.synaptys.com/
Health Care
Manufacturing
Neuroscience
Wellness
Overview

Synaptys Neuroscience
Heat Score
86

Growth Score
pts
in past quarter
Heat Score 86
8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Synaptys Neuroscience

CB Rank
423907
Synaptys Neuroscience is a Biotechnology Research firm developing a new approach to treat people with dementia and alzheimer.
Founded
obfuscation
PrivateNon-equity Assistance Paris, Ile-de-France, France1-10 www.synaptys.com/
Health Care
Manufacturing
Neuroscience
Wellness

Funding Rounds

Non-equity Assistance
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
Phone Number +33 7 83 24 17 56
Contact Email contact@synaptys.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

SYS-0108
A therapeutic drug candidate designed to slow or stop the progression of Alzheimer’s disease by targeting multiple neuronal mechanisms through a combination of molecules.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Synaptys Neuroscience Logo
Non Equity Assistance - Synaptys Neuroscience
1
obfuscation
— Non-equity Assistance

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Monthly Web Visits

66

IT Spend

$431.7KThis year, Synaptys Neuroscience is projected to spend $431.7K on IT, according to Aberdeen.

Active Website Tech Count

2Synaptys Neuroscience is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.

Total IP

1Synaptys Neuroscience has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Synaptys Neuroscience's headquarters? Synaptys Neuroscience is located in Paris, Ile-de-France, France.Who invested in Synaptys Neuroscience? Synaptys Neuroscience is funded by IncubAlliance Paris-Saclay.When was the last funding round for Synaptys Neuroscience? Synaptys Neuroscience closed its last funding round on
obfuscation
from a Non-equity Assistance round.Who are Synaptys Neuroscience's competitors? Alternatives and possible competitors to Synaptys Neuroscience may include Eli Lilly, AbbVie, and  Roche.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|